Literature DB >> 32042687

Evolution of minimal access breast surgery.

Chi Wei Mok1,2, Hung-Wen Lai3,4,5,6,7,8,9,10,11,12.   

Abstract

Surgical management of breast cancer has been evolving rapidly over the past 20-30 years. Prior to this, conventional surgical options were limited to either a mastectomy or breast conserving surgery. The demand for better aesthetic outcomes had driven the development of oncoplastic breast conserving surgery where glandular rearrangement or replacement coupled with thoughtfully placed incisions became the standard approach to breast conserving surgery. As breast surgeons and patients demand for improved aesthetic outcomes, minimally invasive or minimal access breast surgery has gained much attention over the past two decades, from endoscopic assisted to robotic-assisted breast surgery more recently. However, there has been a lack of review articles discussing this relatively recent but under-reported subset of surgical techniques in the management of breast cancer. This article aims to discuss the concept and development of minimal access breast surgery along with a review of current literature on its indications, techniques and outcome measures as well as a discussion on the strengths, limitations as well as future directions. Continued improvement in techniques and advancement of technology will definitely increase the likelihood of minimal access techniques being placed as the standard of care in the management of breast cancer. 2019 Gland Surgery. All rights reserved.

Entities:  

Keywords:  Minimal access; breast surgery; endoscopic; minimally invasive; robotic

Year:  2019        PMID: 32042687      PMCID: PMC6989909          DOI: 10.21037/gs.2019.11.16

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  33 in total

1.  Transareolar endoscopy-assisted partial mastectomy: a preliminary report of six cases.

Authors:  Y Tamaki; I Sakita; Y Miyoshi; M Sekimoto; S Takiguchi; M Monden; S Noguchi
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2001-12       Impact factor: 1.719

Review 2.  Endoscopic breast surgery: where are we now and what might the future hold for video-assisted breast surgery?

Authors:  Daniel Richard Leff; Rajiv Vashisht; Gabriella Yongue; Mohammed Keshtgar; Guang-Zhong Yang; Ara Darzi
Journal:  Breast Cancer Res Treat       Date:  2010-12-03       Impact factor: 4.872

3.  Usefulness of endoscopic breast-conserving surgery for breast cancer.

Authors:  Hiroki Takahashi; Teruhiko Fujii; Shino Nakagawa; Yuka Inoue; Momoko Akashi; Uhi Toh; Nobutaka Iwakuma; Ryuji Takahashi; Miki Takenaka; Eisuke Fukuma; Kazuo Shirouzu
Journal:  Surg Today       Date:  2013-10-24       Impact factor: 2.549

4.  Robotic Nipple-Sparing Mastectomy and Immediate Breast Reconstruction with Gel Implant.

Authors:  Hung-Wen Lai
Journal:  Ann Surg Oncol       Date:  2018-08-25       Impact factor: 5.344

5.  Robotic nipple-sparing mastectomy for the treatment of breast cancer: Feasibility and safety study.

Authors:  Antonio Toesca; Nickolas Peradze; Andrea Manconi; Viviana Galimberti; Mattia Intra; Marco Colleoni; Bernardo Bonanni; Giuseppe Curigliano; Mario Rietjens; Giuseppe Viale; Virgilio Sacchini; Paolo Veronesi
Journal:  Breast       Date:  2016-11-02       Impact factor: 4.380

6.  Early results of an endoscopic nipple-sparing mastectomy for breast cancer.

Authors:  Naomi Sakamoto; Eisuke Fukuma; Kuniki Higa; Shinji Ozaki; Masaaki Sakamoto; Satoko Abe; Terumasa Kurihara; Mitsuhiro Tozaki
Journal:  Indian J Surg Oncol       Date:  2011-03-25

7.  Preliminary results for treatment of early stage breast cancer with endoscopic subcutaneous mastectomy combined with endoscopic sentinel lymph node biopsy in China.

Authors:  Zi-Han Wang; Xiang Qu; Chang-Sheng Teng; Zhi-Cheng Ge; Hui-Ming Zhang; Zhu Yuan; Yin-Guang Gao; Can Lu; Jian-An Yu; Zhong-Tao Zhang
Journal:  J Surg Oncol       Date:  2016-04-04       Impact factor: 3.454

8.  Endoscopic nipple sparing mastectomy with immediate implant-based reconstruction versus breast conserving surgery: a long-term study.

Authors:  Junze Du; Quankun Liang; Xiaowei Qi; Jia Ming; Jing Liu; Ling Zhong; Linjun Fan; Jun Jiang
Journal:  Sci Rep       Date:  2017-03-31       Impact factor: 4.379

9.  Technique for single axillary incision robotic assisted quadrantectomy and immediate partial breast reconstruction with robotic latissimus dorsi flap harvest for breast cancer: A case report.

Authors:  Hung-Wen Lai; Shou-Tung Chen; Shih-Lung Lin; Ya-Ling Lin; Hwa-Koon Wu; Shu-Hsin Pai; Dar-Ren Chen; Shou-Jen Kuo
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

10.  Breast cancer robotic nipple sparing mastectomy: evaluation of several surgical procedures and learning curve.

Authors:  G Houvenaeghel; M Bannier; S Rua; J Barrou; M Heinemann; A Van Troy; E Lambaudie; M Cohen
Journal:  World J Surg Oncol       Date:  2019-02-06       Impact factor: 2.754

View more
  3 in total

1.  Oncologic Outcome of Endoscopic Assisted Breast Surgery Compared with Conventional Approach in Breast Cancer: An Analysis of 3426 Primary Operable Breast Cancer Patients from Single Institute with and Without Propensity Score Matching.

Authors:  Hung-Wen Lai; Shou-Tung Chen; Chiung-Ying Liao; Chi Wei Mok; Ying-Jen Lin; Dar-Ren Chen; Shou-Jen Kuo
Journal:  Ann Surg Oncol       Date:  2021-05-11       Impact factor: 5.344

2.  Association of Long-term Oncologic Prognosis With Minimal Access Breast Surgery vs Conventional Breast Surgery.

Authors:  Andi Wan; Yan Liang; Li Chen; Shushu Wang; Qiyun Shi; Wenting Yan; Xiaozhen Cao; Ling Zhong; Linjun Fan; Peng Tang; Guozhi Zhang; Siyi Xiong; Cheng Wang; Zhen Zeng; Xiujuan Wu; Jun Jiang; Xiaowei Qi; Yi Zhang
Journal:  JAMA Surg       Date:  2022-10-05       Impact factor: 16.681

3.  Minimal Access (Endoscopic and Robotic) Breast Surgery in the Surgical Treatment of Early Breast Cancer-Trend and Clinical Outcome From a Single-Surgeon Experience Over 10 Years.

Authors:  Hung-Wen Lai; Shou-Tung Chen; Ying-Jen Lin; Shih-Lung Lin; Ching-Min Lin; Dar-Ren Chen; Shou-Jen Kuo
Journal:  Front Oncol       Date:  2021-11-19       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.